An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder

Pharmacologic treatment for overactive bladder (OAB), which is characterized by bothersome symptoms such as urgency and urge urinary incontinence (UUI), includes anticholinergics and β(3)-adrenergic receptor agonists. Anticholinergics are associated with adverse effects including dry mouth, constipa...

Descripción completa

Detalles Bibliográficos
Autores principales: Frankel, Jeffrey, Staskin, David, Varano, Susann, Kennelly, Michael J, Jankowich, Rachael A, Haag-Molkenteller, Cornelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901416/
https://www.ncbi.nlm.nih.gov/pubmed/35264853
http://dx.doi.org/10.2147/TCRM.S310371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901416/
https://www.ncbi.nlm.nih.gov/pubmed/35264853
http://dx.doi.org/10.2147/TCRM.S310371

Ejemplares similares